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Abstract
The importance of dysregulation of microRNA (miRNA) expression in nonalcoholic 
steatohepatitis (NASH) has been increasingly recognized; however, the association between 
altered expression of miRNAs and pathophysiological features of NASH and whether or not there 
is a connection between susceptibility to NASH and altered expression of miRNAs are largely 
unknown. In the present study, male inbred C57BL/6J and DBA/2J mice were fed a lipogenic 
methyl-deficient diet that causes liver injury similar to human NASH, and the expression of 
miRNAs and the level of proteins targeted by these miRNAs in the livers were determined. The 
administration of the methyl-deficient diet triggered NASH-specific changes in the livers of 
C57BL/6J and DBA/2J mice with a magnitude being more severe in DBA/2J mice. This was 
evidenced by a greater extent of expression of fibrosis-related genes in the livers of methyl-
deficient DBA/2J mice. The development of NASH was accompanied by prominent changes in 
the expression of miRNAs, including miR-29c, miR-34a, miR-155, and miR-200b. Interestingly, 
changes in the expression of these miRNAs and protein levels of their targets, including Cebp-β, 
Socs 1, Zeb-1, and E-cadherin, in the livers of DBA/2J mice fed a methyl-deficient diet were more 
pronounced as compared to the C57BL/6J mice. These results demonstrate that alterations in 
expression of miRNAs are a prominent event during development of NASH induced by methyl 
deficiency and strongly suggest that severity of NASH and susceptibility to NASH may be 
determined by variations in miRNA expression response. More importantly, our data provide a 
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mechanistic link between alterations in miRNA expression and pathophysiological and 
pathomorphological features of NASH.
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INTRODUCTION
Nonalcoholic fatty liver disease (NAFLD), a hepatic manifestation of the metabolic 
syndrome, and NASH, a progressive form of NAFLD, are two of the most common chronic 
liver diseases in the United States and worldwide.1–3 These two pathological states have 
been shown to progress to cirrhosis and hepatocellular carcinoma.3 The successful 
prevention and treatment of NASH relies on the ability to identify vulnerable subpopulations 
and detect the disease early and greatly depends on a better understanding of the underlying 
molecular mechanisms involved in NASH pathogenesis. It is generally accepted that 
dysregulation of several physiological processes, including lipid metabolism, insulin 
resistance, immune response, inflamation, and oxidative stress, is associated with NASH 
pathogenesis.1,2,4 Additionally, the results of recent studies have established a critical role of 
miRNAs in NASH.5–8 Specifically, expression profiling studies have identified several 
differentially expressed miRNAs, including miR-21, miR-34a, miR-122, miR-155, in 
human5 and mouse NASH,6–8 indicating their role in the pathogenesis of NASH. However, 
despite the current efforts and accomplishments in NASH experimental and clinical research 
and NASH clinical management, major gaps remain in understanding the etiology and 
progression of the disease at the basic level,2,3 particularly, whether or not the different 
susceptibility to NASH is associated with an altered expression of miRNAs.
The differential susceptibility of mice to NASH has been attributed to strain variations in the 
expression of genes involved in hepatic lipid metabolism,9 triglyceride levels,10 oxidative 
stress,11 and c-Myc and NFκB signaling networks.8 Recently, we demonstrated that strain 
differences in the liver epigenomic status are associated with individual susceptibility to 
hepatic steatosis.12 Specifically, feeding DBA/2J mice a lipogenic methyl-deficient diet 
resulted in more prominent epigenetic and pathomorphological changes in the livers as 
compared to C57BL/6J mice.12
The present study was undertaken to: (1) determine the association between altered 
expression of miRNAs and pathophysiological features of NASH in mice; and (2) to 
determine whether or not strain-specific susceptibility of mice to NASH is associated with 
differences in miRNA expression.
MATERIALS AND METHODS
Animals, diets, and experimental design
Male C57BL/6J and DBA/2J mice (Jackson Laboratory, Bar Harbor, ME) were housed in 
sterilized cages in a temperature-controlled (24°C) room, with a 12 hour light/dark cycle, 
and given ad libitum access to purified water and NIH-31 pelleted diet (Purina Mills, 
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Richmond, IN). At eight weeks of age, the mice from each strain were allocated randomly 
into two groups, one control and one experimental. The mice from the experimental group 
were maintained on a low methionine (0.18%) diet, lacking in choline and folic acid (Dyets, 
Inc, Bethlehem, PA), for 12 weeks. The mice from the control group received diet 
supplemented with 0.4% methionine, 0.3% choline bitartrate, and 2 mg/kg folic acid. Diets 
were stored at 4°C and given ad libitum, with twice a week replacement. Five experimental 
and five control mice were sacrificed at 6 and 12 weeks after diet initiation. The livers were 
excised, frozen immediately in liquid nitrogen, and stored at −80°C for subsequent analyses. 
All animal experimental procedures were performed in accordance with the animal study 
protocol approved by the National Center for Toxicological Research Animal Care and Use 
Committee.
Necropsy, tissue processing, and histopathology
The liver tissue samples were processed, analyzed, and scored for steatosis, hepatocellular 
degeneration, inflammation, hepatocellular karyocytomegaly and oval cell proliferation as 
previously described.12
RNA extraction and microarray expression analysis
Total RNA was extracted from liver tissue using miRNAeasy Mini kits (Qiagen, Valencia, 
CA) according to the manufacturer’s instructions. The gene expression profile was 
determined utilizing Agilent whole genome 4×44K mouse microarrays (Agilent 
Technologies, Santa Clara, CA). Sample labeling and microarray processing was performed 
as detailed in the "One-Color Microarray-Based Gene Expression Analysis" version 1.0 
(Agilent Technologies) protocol. The miRNA microarray analysis was performed by LC 
Sciences (Houston, TX), as reported previously in detail.13,14
miRNA expression analysis by quantitative reverse transcription real-time PCR (qRT-PCR)
Total RNA (200 ng) was used for qRT-PCRs of the miR-29c, miR-34a, miR-122, miR-155, 
miR-192, miR-200b, miR-203, and miR-221 utilizing TaqMan miRNA assays (Applied 
Biosystems, Foster City, CA), according to the manufacturer’s instructions. snoRNA202 
was used as an endogenous control. The relative amount of each miRNA was measured 
using the 2−ΔΔCt method.15 All qRT-PCR reactions were conducted in triplicate and 
repeated twice.13,14
Western blot analysis of protein expression
The levels of DNA methyltransferase 1 (Dnmt1), Dnmt3a, Dnmt3b, CCAAT enhancer 
binding protein beta (C/ebp-β), C/ebp-α, suppressor of cytokine signaling-1 (Socs1), E-
cadherin (Cdh1), and β-actin proteins in the livers of control mice and mice fed the methyl-
deficient diet were determined as described previously.12
Transfection of mouse primary hepatocytes with pre-miR-155 and pre-miR-200b
Mouse (CD-1) primary hepatocytes (Invitrogen, Carlsbad, CA) were transfected with 20 nM 
of either pre-miR-155 or pre-miR-200b (20 nM each; Applied Biosystems), in three 
independent replicates, using Lipofectamin™ 2000 transfection reagent (Invitrogen) 
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according to the manufacturer’s instructions. Primary hepatocytes transfected with 
scrambled RNA oligonucleotide served as a control. At 48 hours post-transfection the media 
was changed and transfection was repeated. Forty eight hours after the second transfection, 
adherent cells were harvested by mild trypsinization, washed in phosphate-buffered saline 
(PBS), and the viability of cells was determined. The cells were then immediatelly frozen at 
−80°C for subsequent analyses.
Isolation of hepatic DNA
DNA was extracted by a slight modification of the method reported previously by Nakamura 
et al.16
Liquid chromatography combined with electrospray tandem mass spectrometry (LC-
MS/MS) analyses of 8-oxodeoxyguanosine (8-oxodG)
The measurement of 8-oxodG by LC-MS/MS was adapted from the method described by 
Powel et al.17 DNA samples (30–50 µg) were dissolved in 80 mM Tris-HCl buffer/20 mM 
MgCl2 (pH 7.0) containing 2.75 pmol [15N5]8-OH-dG internal standard and enzymatically 
hydrolyzed to individual nucleosides by incubation with 40 U of DNase I, 2.7 mU of 
phosphodiesterase I, and 2 U of alkaline phosphatase. The released 8-oxodG was purified by 
reverse-phase high-performance liquid chromatography (HPLC) using a Beckman 
Ultrasphere ODS C18 column (5 µm, 4.6 × 250 mm, Beckman, Fullerton, CA). The isocratic 
mobile phase was 7% MeOH in 10 mM ammonium formate (pH 4.3) with a flow rate of 1 
ml/min. Fractions were collected 2 min intervals preceding and following the elution of 8-
oxodG. The quantitative analysis of 8-oxodG by LC-MS/MS was performed with a 1100 
capillary high-performance liquid chromatograph (Agilent, Wilmington, DE) coupled to a 
TSQ-Quantum triple quad mass analyzer (ThermoFinnigan, San Jose, CA). A 3.5-µm 
Zorbax XDB-C18 column (0.3 × 150 mm; Agilent) was operated with a binary mobile phase 
of 2% 10 mM ammonium formate (pH 4.3) and 98% methanol followed by a linear gradient 
increase of methanol from 2% to 30% from 0 to 5 min, holding at 30% for 10 min, and 
immediately returned to initial conditions that were held for 15 min. Both 8-oxodG and 
[15N5]8-OH-dG internal standard were detected by single reaction monitoring of the 
transition of nucleoside to base adduct m/z 284.2 to 168.2 and m/z 289.2 to 173.2, 
respectively. MS conditions were as follows: spray voltage, 2200 V and heated capillary 
temperature, 350°C. All reagents were purchased from Sigma-Aldrich (St. Louis, MO) and 
were of ACS grade or higher.
Determination of genomic and mitochondrial DNA damage
The extent of genomic DNA damage was determined by measuring the levels of histone 
H2AX phosphorylation and histone H4 lysine 20 dimethylation by Western 
immunoblotting.12,18 The extent of mitochondrial DNA was determined by a quantitative 
PCR technique (qPCR).19,20
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Results are presented as mean ± S.E.M. Statistical analyses were conducted by two-way 
ANOVA, using diet and strain as fixed factors. Pair-wise comparisons were conducted by 
the Student-Newman-Keuls test. P-values <0.05 were considered significant.
RESULTS
Expression of fibrosis-relevant genes in the livers of C57BL/6J and DBA/2J mice fed a 
methyl-deficient diet
The results of our previous study demonstrated that DBA/2J mice are more susceptible to 
NASH induced by methyl-deficiency than C57BL/6J.12 In order to further confirm that 
finding, we analyzed the histomorphological changes and the expression level of several 
critical fibrosis-associated genes,21 including tumor necrosis factor alpha (Tnf), procollagen 
(Col) genes, platelet-derived growth factor (Pdgf) C and D, platelet-derived growth factor 
receptor (Pdgfr) alpha, and matrix metallopeptidase (Mmp) 2 and 3, in the livers of 
C57BL/6J and DBA/2J mice fed the methyl-deficient diet for 12 weeks. Feeding a methyl-
deficient diet resulted more pronounced pathological changes in the livers of DBA/2J mice 
as compared to C57BL/6J mice (Suppl. Fig. 1) and a greater up-regulation of Col1a1, 
Col1a2, Col3a1, Col4a6, Col5a2, Col6a1, Col16a1, Pdgfc, Pdgfd, Pdgfrα, Mmp2, and 
Mmp3 genes in livers of methyl-deficient DBA/2J mice than in C57BL/6J mice (Suppl. 
Table 1).
Effects of methyl-deficient diet on the extent of genomic and mitochondrial DNA damage 
in the livers of C57BL/6J and DBA/2J mice
Another well-documented fundamental event in the development of NASH is mitochondrial 
dysfunction and induction of oxidative stress.2,4,22 In view of this, we studied the extent of 
genomic and mitochondrial DNA damage in the livers of C57BL/6J and DBA/2J mice fed a 
methyl-deficient diet. Fig. 1A shows that in livers of control mice, the level of 8-oxodG did 
not change over the 12 week period. Administration of the methyl deficient diet to DBA/2J 
mice resulted in progressive accumulation of 8-oxodG in hepatic DNA with a difference 
being significant after 6 and 12 weeks of deficiency (Fig. 1A). In contrast, in the livers of 
C57BL/6J mice fed a methyl-deficient diet the levels of 8-oxodG slightly increased after 12 
weeks only.
In addition to the increased levels of 8-oxodG in DNA, the livers from methyl-deficient 
C57BL/6J and DBA/2J mice were characterized by an increased level of histone H2AX 
phosphorylation (Fig. 1B) and histone H4 lysine 20 dimethylation (data not shown), 
dependable markers for DNA damage. However, the magnitude of DNA damage in the 
livers of DBA/2J mice was more pronounced compared to the C57BL/6J strain, with the 
difference being significant after 12 weeks on a diet (Fig. 1B). Feeding mice the methyl-
deficient diet also resulted in mitochondrial DNA damage, with extent being greater in 
DBA/2J (Fig 1C).
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Dysregulation of miRNAs in the livers of C57BL/6J and DBA/2J mice fed a methyl-deficient 
diet
miRNA microarrays were used to analyze the miRNA expression profiles in the livers of 
control C57BL/6J mice and C57BL/6J mice fed a methyl-deficient diet that causes a 
pathological state similar to human NASH.6,23,24 It is believed that that this model is the 
best-established experimental model to study NASH.25 We identified 74 miRNAs (40 up-
regulated and 34 down-regulated) that were differentially expressed (p<0.05) after 12 weeks 
of methyl deficiency (Suppl. Fig. 2). The expression of the most altered miRNAs (miR-29c, 
miR-34a, miR-122, miR-155, miR-192, miR-200b, miR-203, and miR-221) in the livers of 
C57BL/6J mice fed the methyl-deficient diet was confirmed by qRT-PCR. Additionally, we 
analyzed the expression of these miRNAs in the livers of control DBA/2J mice and DBA/2J 
fed the methyl-deficient diet. Interestingly, we detected an increased expression of miR-34a, 
miR-155, and miR-200b in the livers of both C57BL/6J and DBA/2J mice fed the methyl 
deficient diet for 12 weeks, with a magnitude being significantly greater in DBA/2J mice 
(Table 1). Specifically, the expression of miR-34a, miR-155, and miR-200b in the livers of 
DBA/2J mice fed a methyl-deficient diet was 4.9, 5,9, and 2.9 times greater than in 
C57BL/6J mice. In contrast, the livers of C57BL/6J mice fed the methyl-deficient diet were 
characterized by pronounced down-regulation of miR-29c, whereas its expression in the 
livers of DBA/2J mice did not change.
Protein level of miRNA targets in the livers of C57BL/6J and DBA/2J mice fed a methyl-
deficient diet
To establish the significance of miRNA dysregulation in the pathogenesis of NASH, 
specifically, whether or not the aberrant expression of miRNAs is associated with 
pathophysiological features of NASH-induced liver injury, we determined protein levels of 
the targets of the most differentially expressed miRNAs. The results of recent studies have 
demonstrated that the targets for miR-155 are C/ebp-β,6,26 a liver-enriched transcription 
factor, and Socs1 tumor suppressor.27 Fig. 2 shows that the increased expression of miR-155 
in the livers of C57BL/6J and DBA/2J methyl-deficient mice (Fig. 2A) was associated with 
the decreased levels of C/ebp-β and Socs1 proteins (Fig 2B). Furthermore, the increase in 
miR-155 and decrease in C/ebp-β and Socs1 was more pronounced in the livers of DBA/2J 
mice (Fig. 2).
The experimentally confirmed targets for miR-29 family are de novo DNA 
methyltransferases Dnmt3a and Dnmt3b.28 Fig. 3 shows that down-regulation of miR-29c 
(Fig. 3A) was associated with increased protein levels of Dnmt3a and Dnmt3b in the livers 
of C57BL/6J mice fed the methyl-deficient diet (Fig. 3B) as compared to age-matched 
control C57BL/6J mice. In contrast, the expression of miR-29 and the level of Dnmt3a and 
Dnmt3b proteins in the livers of DBA/2J mice fed the methyl-deficient diet did not change 
(Fig. 3).
Feeding C57BL/6J and DBA/2J mice a methyl-deficient diet for 12 weeks resulted in 
substantial up-regulation of miR-200b (Fig. 4A) and down-regulation of its Zeb1 target29 
(Fig. 4B), a well-known transcriptional repressor of E-cadherin, by 26% and 52%, 
respectively. The decreased Zeb1 levels in the livers of C57BL/6J and DBA/2J mice 
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exposed to methyl deficiency were accompanied consequently with 2.2 and 3.3 times up-
regulation of E-cadherin (Cdh1) protein level, respectively, as compared to age-matched 
control mice (Fig 4B). Interestingly, a greater increase of E-cadherin protein in the livers of 
methyl-deficient DBA/2J mice corresponded to a greater expression of miR-200b. In 
contrast, the protein level of C/ebp-α, another predicted target for mouse miR-200b, did not 
change in the livers of C57BL/6J mice fed the methyl-deficient diet, and slightly decreased 
in DBA/2J mice (Fig. 4B).
Ectopic up-regulation of miR-155 and miR-200b in mouse primary hepatocytes
In order to confirm that altered levels of C/ebp-β, Socs1, and E-cadherin proteins in the 
livers of mice fed a methyl-deficient diet are associated with aberrant expression of miR-155 
and miR-200b, we transfected mouse primary hepatocytes with these microRNAs. Fig. 5 
shows that ectopic up-regulation of miR-155 in mouse primary hepatocytes was 
accompanied by a decreased level of C/ebp-β and Socs1 proteins, while the level of these 
proteins remained unchanged in hepatocytes transfected with miR-200b (Fig. 5). Similarly, 
transfection of hepatocytes with miR-200b up-regulated the level of E-cadherin (Cdh1) only.
DISCUSSION
The current view on the pathogenesis of NASH favors a model in which NASH is associated 
with altered hepatic lipid metabolism, inflammation, and oxidative stress; however, the 
underlying mechanisms of these pathophysiological processes are not fully understood. The 
results of the present study demonstrate that feeding of C57BL/6J and DBA/2J mice a 
methyl-deficient diet, which is known to induce NASH in mice,6,23,24 results in aberrant 
expression of miRNAs, specifically miR-29c, miR-34a, miR-122, miR-155, miR-192, 
miR-200b, miR-203, and miR-221. Similar findings have been reported recently by Wang et 
al.6 during NASH-induced hepatocarcinogenesis in mice fed a choline-deficient and amino 
acid-defined diet. Additionally, the present study demonstrates the association of aberrant 
expression of miRNAs with fundamental pathophysiological features of NASH. These data 
indicate that dysregulation of miRNA expression is a critical event in the pathogenesis of 
NASH. More importantly, the results of our study demonstrate that strain-specific 
differences in susceptibility of mice to NASH are associated with differences in miRNA 
expression. Specifically, DBA/2J mice, a strain that develops more prominent NASH-
specific changes, evidenced by more severe pathomorphological changes12 (Suppl. Fig. 1) 
and greater up-regulation of fibrosis-related genes (Suppl. Table 1) as compared to 
C57BL/6J mice, were characterized by a greater magnitude of miRNA expression changes 
in the livers.
The key pathophysiological features of NASH are an altered lipid metabolism and 
hepatocyte apoptosis.30,31 The results of our study demonstrate a profound down-regulation 
of miR-122, a liver–specific miRNA, which is important for normal lipid metabolism,32,33 
and dramatic up-regulation of miR-34a, a critical regulator of apoptosis,34 in the livers of 
mice fed a methyl-deficient diet (Table 1). These changes correspond to more pronounced 
triglyceride accumulation and more severe cell death in the DBA/2J mice fed a methyl-
deficient diet as detected in our previous study12 and present study. Several recent reports 
Pogribny et al. Page 7






















have shown that miRNAs miR-122 and miR-34a are two of the most frequently 
dysregulated miRNAs in NASH.5,35 Specifically, increased expression of miR-34a and 
decreased expression of miR-122 have been demonstrated recently in the livers of ob/ob 
mice, a well-established hyperglycemic model of NAFLD, and in streptozotocin-induced 
type 1 diabetic mice.35 These are two main risk factors for the development of NAFLD and 
NASH in humans. Indeed, similar dysregulation in expression of miR-34a and miR-122 has 
been reported in human NASH.5
The results of a recent study have demonstrated the importance of miR-155 up-regulation in 
NASH-induced hepatocarcinogenesis.6 miR-155 targets two critical tumor suppressors C/
ebp-β and Socs126,27 that are frequently down-regulated in hepatocellular carcinomas and 
hepatoblastomas.36–38 Moreover, in our previous study we demonstrated that inhibition of 
Socs1 expression is a critical event in hepatocarcinogenesis.39 In addition to the crucial role 
of Socs1 as a negative regulator of cytokine-induced signal transduction pathway,40 Socs1 
acts as an important mediator of cellular oxidative stress.41 It is well-known that several 
hepatic genes, including methionine adenosyltransferase 1a (Mat1a) and catalase, involved 
in regulation of oxidative stress and frequently down-regulated in NASH also,42–44 are 
regulated by C/ebp-β.45,46 This corresponds to the results of our study that demonstrate the 
induction of oxidative stress (Figure 5), another key event in the pathogenesis of 
NASH,2,4,22 in the livers of mice fed the methyl-deficient diet.
In a previous study,12 we demonstrated that feeding DBA/2J mice a lipogenic methyl-
deficient diet resulted also in more prominent epigenetic changes in the livers of DBA/2J 
mice as compared to C57BL/6J mice. Specifically, administration of a methyl-deficient diet 
to C57BL/6J and DBA/2J mice resulted in a pronounced demethylation of genomic DNA 
and repetitive elements, with the magnitude being greater in DBA/2J mice. The results of 
our present study indicate that the greater degree of demethylation of genomic DNA and, 
particularly, repetitive elements in the livers of methyl-deficient DBA2J mice compared to 
methyl-deficient C57BL/6J mice may be associated with the miR-29-driven differences in 
DNMTs expression (Figure 3). It has been shown that cooperation between Dnmt1 and de 
novo DNA methyltransferases Dnmt3a and Dnmt3b is absolutely required for the 
maintenance of the methylation of repetitive elements and that Dnmt1 by itself is not 
capable of maintaining methylation of repetitive elements.47 Therefore, the decreased 
miR-29 expression and consequent up-regulation of Dnmt3a and Dnmt3b may be a 
mechanism that protects the genome from excessive demethylation.
Differential expression of the miR-200 family, including miR-200b, miR-200c, and 
miR-429, in the livers of methyl-deficient C57BL/6J and DBA/2J mice is an important 
finding of the study. These miRNAs target transcriptional repressors of E-cadherin, ZEB1 
and ZEB2,29,48 resulting in increased expression of E-cadherin. Importantly, increased E-
cadherin expression starting at preneoplastic stages has been associated with a more 
aggressive hepatocarcinogenic process in mice.49
The results of our in vitro experiments confirmed the mechanistic link between altered 
expression of miR-155 and miR-200b and their targets. Likewise, in our previous study we 
have demonstrated that transfection of rat hepatocytes with miR-34a induced apoptosis.50
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In conclusion, these findings demonstrate that alterations in the expression of miRNAs are a 
prominent event in NASH induced by methyl deficiency in mice and strongly suggest that 
differences in the susceptibility to NASH and the severity of NASH may be determined by 
the variations in miRNA expression response. More importantly, our data provide a 
mechanistic link between alterations in miRNA expression and pathophysiological and 
pathomorphological features of NASH. Additional studies will be necessary to determine 
whether or not altered expression of miRNAs, by itself, may induce the development of 
NASH and if miRNA correction weakens NASH symptoms and decreases NASH 
progression.
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NAFLD nonalcoholic fatty liver disease
NASH nonalcoholic steatohepatitis
Pdgf platelet-derived growth factor
Pdgfr platelet-derived growth factor receptor
8-oxodG 8-oxodeoxyguanosine
Socs1 suppressor of cytokine signaling-1
Tnf tumor necrosis factor alpha
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Figure 1. Genomic and mitochondrial DNA damage in the livers of C57BL/6J and DBA/2J mice 
fed control and methyl-deficient diet for 12 weeks
(A) Levels of 8-oxodG in DNA in the livers of C57BL/6J and DBA/2J mice fed control or a 
methyl-deficient diet for 12 weeks. (B) Western blot analysis of histone H2AX 
phosphorylation. (C) Level of mitochondrial DNA damage as detected by qPCR. Data are 
presented as mean ± S.D. (n=5).
* Significantly different from age-matched control mice. ** Significantly different from 
methyl-deficient C57BL/6J mice.
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Figure 2. Expression changes of miR-155 and C/ebp-β and Socs1 proteins in the livers of 
C57BL/6J and DBA/2J mice fed control and methyl-deficient diet (MDD) for 12 weeks
(A) qRT-PCR analysis of miR-155 expression. The miRNA expression data are presented as 
average fold change normalized to snoRNA-202 in the livers of methyl-deficient mice 
compared to control mice. The level of miRNA expression was measured using the 2−ΔΔCt 
method.15 These results were reproduced in two independent experiments. (B) Western blot 
analysis of C/ebp-β and Socs1 proteins. Liver tissue lysates were separated by SDS-PAGE 
and subjected to Western immunoblotting using specific antibodies against C/ebp-β and 
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Socs1 proteins. Equal sample loading was confirmed by immunostaining against β-actin. 
These results were reproduced in two independent experiments. Representative Western 
immunoblot images are shown. Chemiluminescence detection was performed with the 
Immobilon Western Chemiluminescent HRP Substrate (Millipore Corporation) and 
measured directly by a BioSpectrum Imaging System (UVP). The signal intensity was 
analyzed by ImageQuant software (Molecular Dynamics). Data are presented as mean ± 
S.D. (n=5).
* Significantly different from age-matched control mice. ** Significantly different from 
methyl-deficient C57BL/6J mice.
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Figure 3. Expression changes of miR-29c and Dnmt1, Dnmt3a, and Dnmt3b proteins in the livers 
of C57BL/6J and DBA/2J mice fed control and methyl-deficient diet for 12 weeks
(A) qRT-PCR analysis of miR-29c expression. (B) Western blot analysis of Dnmt1, 
Dnmt3a, and Dnmt3b proteins. Data are presented as mean ± S.D. (n=5).
* Significantly different from age-matched control mice. ** Significantly different from 
methyl-deficient C57BL/6J mice.
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Figure 4. Expression changes of miR-200b and Cdh1 and C/ebp-α proteins in the livers of 
C57BL/6J and DBA/2J mice fed control and methyl-deficient diet for 12 weeks
(A) qRT-PCR analysis of miR-200b expression. (B) Western blot analysis of Cdh1 and C/
ebp-α proteins. Data are presented as mean ± S.D. (n=5).
* Significantly different from age-matched control mice. ** Significantly different from 
methyl-deficient C57BL/6J mice.
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Figure 5. Western blot analysis of C/ebp-β, Socs1, and Cdh1 proteins in mouse primary 
hepatocytes transfected with pre-mir-155 or pre-miR-200b
Mouse primary hepatocytes were transfected with 20 nM of either pre-miR-155 or pre-
miR-200b. Mouse primary hepatocytes transfected with scrambled RNA oligonucleotide 
(mock) served as a control.
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Table 1




Control MD diet Control MD diet
Up-regulated
miR-34a 1.00 ± 0.07 3.62 ± 1.18* 1.01 ± 0.15 17.57 ± 3.75*
miR-155 0.96 ± 0.31 2.56 ± 0.68* 1.00 ± 0.06 15.08 ± 0.80*
miR-200b 1.08 ± 0.35 6.41 ± 0.76* 1.02 ± 0.24 18.86 ± 3.26*
miR-221 1.33 ± 0.42 2.74 ± 0.58* 1.02 ± 0.22 2.42 ± 0.44*
Down-regulated
miR-29c 1.06 ± 0.38 0.49 ± 0.13* 1.01 ± 0.13 0.90 ± 0.10
miR-122 1.03 ± 0.22 0.28 ± 0.06* 1.03 ± 0.28 0.39 ± 0.05*
miR-192 0.97 ± 0.09 0.33 ± 0.14* 1.00 ± 0.05 0.41 ± 0.04*
miR-203 1.15 ± 0.23 0.55 ± 0.15* 1.01 ± 0.17 0.56 ± 0.09*
*
- Significantly different from the control, p<0.05.
Data presented as mean±S.D., n=5.
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